Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

The L2a element is a mouse CD8 silencer that interacts with MAR-binding proteins SATB1 and CDP.

Yao X, Nie H, Rojas IC, Harriss JV, Maika SD, Gottlieb PD, Rathbun G, Tucker PW.

Mol Immunol. 2010 Nov-Dec;48(1-3):153-63. doi: 10.1016/j.molimm.2010.08.014. Epub 2010 Sep 29.

2.

Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development.

Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, Sambandam A, Willen J, Bunte RM, Maika SD, Harriss JV, Caton AJ, Bhandoola A, Tucker PW, Hu H.

Blood. 2010 Jan 21;115(3):510-8. doi: 10.1182/blood-2009-07-232694. Epub 2009 Nov 12.

3.

Developmental and species-divergent globin switching are driven by BCL11A.

Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, Maika SD, Fujiwara Y, Ito M, Groudine M, Bender MA, Tucker PW, Orkin SH.

Nature. 2009 Aug 27;460(7259):1093-7. doi: 10.1038/nature08243. Epub 2009 Aug 5.

4.

SATB1 is required for CD8 coreceptor reversal.

Nie H, Yao X, Maika SD, Tucker PW.

Mol Immunol. 2008 Nov;46(1):207-11. doi: 10.1016/j.molimm.2008.07.007. Epub 2008 Aug 21.

5.

Epitope tagging of proteins at the native chromosomal loci of genes in mice and in cultured vertebrate cells.

Chen YI, Maika SD, Stevens SW.

J Mol Biol. 2006 Aug 18;361(3):412-9. Epub 2006 Jul 7.

PMID:
16859702
6.
7.

Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis.

Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV, Maika SD, Kuziel WA, King HL, Olson EN, Nakagawa O, Srivastava D.

Nat Genet. 2002 May;31(1):25-32. Epub 2002 Apr 1.

PMID:
11923873
8.

A new MHC locus that influences class I peptide presentation.

Taurog JD, Lindahl KF, Hammer RE, Slaughter CA, Maika SD, Zhou M, Roopenian DC, Christianson GJ, Gaskell SJ, Jones RC, Bordoli R, Ploegh HL, Galocha B, Summerfield SG.

Immunity. 1999 Oct;11(4):following 506. No abstract available.

9.

Inflammatory disease in HLA-B27 transgenic rats.

Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, Sayad A, Stagg AJ, Fox GM, Lê O'Brien A, Rehman M, Zhou M, Weiner AL, Splawski JB, Richardson JA, Hammer RE.

Immunol Rev. 1999 Jun;169:209-23. Review.

PMID:
10450519
10.

Analysis of genomic regions involved in regulation of the rabbit surfactant protein A gene in transgenic mice.

Alcorn JL, Hammer RE, Graves KR, Smith ME, Maika SD, Michael LF, Gao E, Wang Y, Mendelson CR.

Am J Physiol. 1999 Aug;277(2):L349-61. doi: 10.1152/ajplung.1999.277.2.L349.

PMID:
10444530
11.

The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.

Zhou M, Sayad A, Simmons WA, Jones RC, Maika SD, Satumtira N, Dorris ML, Gaskell SJ, Bordoli RS, Sartor RB, Slaughter CA, Richardson JA, Hammer RE, Taurog JD.

J Exp Med. 1998 Sep 7;188(5):877-86. Erratum in: J Exp Med 2000 Feb 21;191(4):following 746.

12.

A new MHC locus that influences class I peptide presentation.

Simmons WA, Roopenian DC, Summerfield SG, Jones RC, Galocha B, Christianson GJ, Maika SD, Zhou M, Gaskell SJ, Bordoli RS, Ploegh HL, Slaughter CA, Lindahl KF, Hammer RE, Taurog JD.

Immunity. 1997 Nov;7(5):641-51. Retraction in: Taurog JD, Lindahl KF, Hammer RE, Slaughter CA, Maika SD, Zhou M, Roopenian DC, Christianson GJ, Gaskell SJ, Jones RC, Bordoli R, Ploegh HL, Galocha B, Summerfield SG. Immunity. 1999 Oct;11(4):following 506.

13.

Rat spermatogenesis in mouse testis.

Clouthier DE, Avarbock MR, Maika SD, Hammer RE, Brinster RL.

Nature. 1996 May 30;381(6581):418-21.

14.

T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.

Breban M, Fernández-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, Taurog JD.

J Immunol. 1996 Jan 15;156(2):794-803.

PMID:
8543835
15.

Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats.

Kasof GM, Mandelzys A, Maika SD, Hammer RE, Curran T, Morgan JI.

J Neurosci. 1995 Jun;15(6):4238-49.

16.

E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice.

Comerford SA, Maika SD, Laimins LA, Messing A, Elsässer HP, Hammer RE.

Oncogene. 1995 Feb 2;10(3):587-97.

PMID:
7845684
17.

Apo(a) expression in transgenic mice.

Hobbs HH, Chiesa G, Gaw A, Lawn R, Maika SD, Koschinsky M, Hammer R.

Ann N Y Acad Sci. 1994 Apr 18;714:231-6. Review. No abstract available.

PMID:
8017772
18.

A new transgenic mouse model of chronic hyperglycemia.

Schaefer EM, Viard V, Morin J, Ferré P, Pénicaud L, Ramos P, Maika SD, Ellis L, Hammer RE.

Diabetes. 1994 Jan;43(1):143-53. Erratum in: Diabetes 1994 Feb;43(2):340.

PMID:
7505243
19.

Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE.

J Immunol. 1993 May 1;150(9):4168-78.

PMID:
8473755
20.

Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a).

Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE.

J Biol Chem. 1992 Dec 5;267(34):24369-74.

21.
22.

Physical analysis of phr gene transcription in Escherichia coli K-12.

Lorence MC, Maika SD, Rupert CS.

J Bacteriol. 1990 Nov;172(11):6551-6.

Supplemental Content

Loading ...
Support Center